Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Annals of the Rheumatic Diseases 1995;54:801-806; doi:10.1136/ard.54.10.801
Copyright © 1995 BMJ Publishing Group Ltd & European League Against Rheumatism

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peel, N F
Right arrow Articles by Eastell, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peel, N F
Right arrow Articles by Eastell, R

Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis.

N F Peel , D J Moore , N A Barrington , D E Bax , R Eastell

Department of Human Metabolism and Clinical Biochemistry, University of Sheffield, United Kingdom.

OBJECTIVES--To determine the prevalence of vertebral fracture in postmenopausal women with steroid treated rheumatoid arthritis (RA), and whether the risk of vertebral fracture could be predicted from measurements of bone mineral density (BMD). METHODS--Vertebral deformities were defined from spine radiographs in 76 postmenopausal women with steroid treated RA (aged 50-79 years) and 347 age matched women from a population based group, using a morphometric technique. Lumbar spine (LS) BMD was measured by dual energy x ray absorptiometry. RESULTS--The odds ratio for vertebral fracture in the women with RA was 6.2 (95% confidence interval 3.2 to 12.3). The decrease in LS-BMD was less than expected for the observed prevalence of vertebral fracture and, among the women with RA, LS-BMD was not lower in those with vertebral fractures. CONCLUSIONS--We conclude that patients with steroid treated RA may have abnormal bone quality, and that LS-BMD cannot be used to predict the risk of vertebral fracture in these patients.





This article has been cited by other articles:


Home page
Ann Rheum DisHome page
M Guler-Yuksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, J K de Vries-Bouwstra, H M J Hulsmans, W M de Beus, K H Han, F C Breedveld, B A C Dijkmans, C F Allaart, et al.
Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis
Ann Rheum Dis, June 1, 2008; 67(6): 823 - 828.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M Guler-Yuksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, F C Breedveld, C F Allaart, J K de Vries-Bouwstra, B A C Dijkmans, W F Lems, H K Ronday, A J Peeters, et al.
Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis
Ann Rheum Dis, November 1, 2007; 66(11): 1508 - 1512.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
G. Saviola, L. Abdi. Ali, S. Shams. Eddin, A. Coppini, F. Cavalieri, L. Campostrini, S. Sacco, M. Bucci, G. Cirino, and M. Rossini
Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study
Rheumatology, June 1, 2007; 46(6): 994 - 998.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Chavassieux, E. Seeman, and P. D. Delmas
Insights into Material and Structural Basis of Bone Fragility from Diseases Associated with Fractures: How Determinants of the Biomechanical Properties of Bone Are Compromised by Disease
Endocr. Rev., April 1, 2007; 28(2): 151 - 164.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
H. Prather, L. Van Dillen, J. P. Metzler, K. D. Riew, and L. A. Gilula
Prospective Measurement of Function and Pain in Patients with Non-Neoplastic Compression Fractures Treated with Vertebroplasty
J. Bone Joint Surg. Am., February 1, 2006; 88(2): 334 - 341.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
R E Orstavik, G Haugeberg, T Uhlig, P Mowinckel, T K Kvien, J A Falch, and J I Halse
Quantitative ultrasound and bone mineral density: discriminatory ability in patients with rheumatoid arthritis and controls with and without vertebral deformities
Ann Rheum Dis, August 1, 2004; 63(8): 945 - 951.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. A. O'Brien, D. Jia, L. I. Plotkin, T. Bellido, C. C. Powers, S. A. Stewart, S. C. Manolagas, and R. S. Weinstein
Glucocorticoids Act Directly on Osteoblasts and Osteocytes to Induce Their Apoptosis and Reduce Bone Formation and Strength
Endocrinology, April 1, 2004; 145(4): 1835 - 1841.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. E. Orstavik, G. Haugeberg, P. Mowinckel, A. Hoiseth, T. Uhlig, J. A. Falch, J. I. Halse, E. McCloskey, and T. K. Kvien
Vertebral Deformities in Rheumatoid Arthritis: A Comparison With Population-Based Controls
Arch Intern Med, February 23, 2004; 164(4): 420 - 425.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
R E Orstavik, G Haugeberg, T Uhlig, P Mowinckel, J A Falch, J I Halse, and T K Kvien
Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables
Ann Rheum Dis, February 1, 2004; 63(2): 177 - 182.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
N. Porter, H.L. Beynon, and H.S. Randeva
Endocrine and reproductive manifestations of sarcoidosis
QJM, August 1, 2003; 96(8): 553 - 561.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
S. S. Yeap and D. J. Hosking
Management of corticosteroid-induced osteoporosis
Rheumatology, October 1, 2002; 41(10): 1088 - 1094.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. J. Walsh, S. A. Lewis, C. A. Wong, S. Cooper, J. Oborne, S. A. Cawte, T. Harrison, D. J. Green, M. Pringle, R. Hubbard, et al.
The Impact of Oral Corticosteroid Use on Bone Mineral Density and Vertebral Fracture
Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 691 - 695.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
O R Madsen, O H Sorensen, and C Egsmose
Bone quality and bone mass as assessed by quantitative ultrasound and dual energy x ray absorptiometry in women with rheumatoid arthritis: relationship with quadriceps strength
Ann Rheum Dis, April 1, 2002; 61(4): 325 - 329.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
B Gudbjornsson, U I Juliusson, and F V Gudjonsson
Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice
Ann Rheum Dis, January 1, 2002; 61(1): 32 - 36.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
L J Walsh, C A Wong, J Oborne, S Cooper, S A Lewis, M Pringle, R Hubbard, and A E Tattersfield
Adverse effects of oral corticosteroids in relation to dose in patients with lung disease
Thorax, April 1, 2001; 56(4): 279 - 284.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
V. Naganathan, G. Jones, P. Nash, G. Nicholson, J. Eisman, and P. N. Sambrook
Vertebral Fracture Risk With Long-term Corticosteroid Therapy: Prevalence and Relation to Age, Bone Density, and Corticosteroid Use
Arch Intern Med, October 23, 2000; 160(19): 2917 - 2922.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
T. K Kvien, G. Haugeberg, T. Uhlig, J. A Falch, J. I Halse, W. F Lems, B. A C Dijkmans, and A. D Woolf
Data driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk of osteoporosis
Ann Rheum Dis, October 1, 2000; 59(10): 805 - 811.
[Abstract] [Full Text]


Home page
Rheumatology (Oxford)Home page
M. Conron, C. Young, and H. L. C. Beynon
Calcium metabolism in sarcoidosis and its clinical implications
Rheumatology, July 1, 2000; 39(7): 707 - 713.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M E LLOYD, T D SPECTOR, and R HOWARD
Osteoporosis in neurological disorders
J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 543 - 547.
[Full Text]


Home page
Rheumatology (Oxford)Home page
D. Jardinet, C. Lefebvre, G. Depresseux, M. Lambert, J.-P. Devogelaer, and F. A. Houssiau
Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine
Rheumatology, April 1, 2000; 39(4): 389 - 392.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
I.-M. Gilboe, T. K Kvien, G. Haugeberg, and G. Husby
Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls
Ann Rheum Dis, February 1, 2000; 59(2): 110 - 115.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
W F LEMS and B A C DIJKMANS
Should we look for osteoporosis in patients with rheumatoid arthritis?
Ann Rheum Dis, June 1, 1998; 57(6): 325 - 327.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1995 BMJ Publishing Group Ltd & European League Against Rheumatism